Medpace Holdings, Inc. (MEDP) Dividend History

Medpace Holdings, Inc. is a global contract research organization (CRO) that provides comprehensive clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace specializes in conducting clinical trials across various therapeutic areas, offering expertise in regulatory affairs, data management, and project management to support drug development and approval processes.

5375 Medpace Way, Cincinnati, OH, 45227
Phone: (513) 579-9911
Website: https://www.medpace.com

Dividend History

Medpace Holdings, Inc. currently does not pay dividends

Company News

  • Preclinical CRO Market Size at USD 6.8 Billion in 2025, Forecasted to Grow at 8.73% CAGR Through 2034

    The global preclinical Contract Research Organization (CRO) market is projected to grow from USD 6.8 billion in 2025 to USD 14.34 billion by 2034, driven by increased pharmaceutical R&D, technological advancements, and demand for specialized research services.

    GlobeNewswire Inc.
    Featured Companies: CRL TMO
  • HQY vs. MEDP: Which Stock Is the Better Value Option?

    The article compares the valuation metrics of HealthEquity (HQY) and Medpace (MEDP) to determine which stock is the better value option. Based on factors like Zacks Rank, forward P/E, and PEG ratio, the article concludes that HQY is the superior value option.

    Benzinga
    Featured Companies: HQY
  • SGRY or MEDP: Which Is the Better Value Stock Right Now?

    The article compares Surgery Partners (SGRY) and Medpace (MEDP) to determine which is the better value stock. It analyzes various valuation metrics and concludes that SGRY is the superior value option based on its improving earnings outlook and more favorable valuation metrics.

    Zacks Investment Research

Related Companies

Page data last updated 07/23/2025 02:14:27 UTC